PCA
Private Capital Advisors Portfolio holdings
AUM
$821M
1-Year Return
5.72%
This Quarter Return
+11.1%
1 Year Return
+5.72%
3 Year Return
+100.45%
5 Year Return
+227.97%
10 Year Return
+492.43%
AUM
$292M
AUM Growth
+$16.8M
(+6.1%)
Cap. Flow
-$4.1M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
29.91%
Holding
120
New
8
Increased
27
Reduced
29
Closed
13
Top Buys
| 1 |
Sangamo Therapeutics
SGMO
|
$14.7M |
| 2 |
Arrowhead Research
ARWR
|
$4.09M |
| 3 |
Biogen
BIIB
|
$2.98M |
| 4 |
Gilead Sciences
GILD
|
$1.74M |
| 5 |
Baidu
BIDU
|
$1.67M |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$6.53M |
| 2 |
Celldex Therapeutics
CLDX
|
$6.14M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$5.35M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
$5.12M |
| 5 |
Noodles & Co
NDLS
|
$2.64M |
Sector Composition
| 1 | Healthcare | 23.2% |
| 2 | Communication Services | 13.78% |
| 3 | Energy | 13.38% |
| 4 | Industrials | 9.86% |
| 5 | Consumer Discretionary | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
APC
26
DELISTED
Anadarko Petroleum
APC
| $4.15M | 1.42% |
52,345
+425
| +0.8% | +$33.7K |
|
27
3M
MMM
$81.3B
| $4.15M | 1.42% |
35,396
-221
| -0.6% | -$25.9K |
|
|
28
Biogen
BIIB
$20.2B
| $4.1M | 1.4% |
14,675
+10,675
| +267% | +$2.98M |
|
|
TFCFA
29
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $4.1M | 1.4% |
116,665
+1,050
| +0.9% | +$36.9K |
|
|
30
Arrowhead Research
ARWR
$3.8B
| $4.09M | 1.4% |
+377,017
| New | +$4.09M |
|
|
31
Alphabet (Google) Class C
GOOG
$2.76T
| $4.02M | 1.38% |
144,178
-191,716
| -57% | -$5.35M |
|
32
Canadian National Railway
CNI
$60.1B
| $3.98M | 1.36% |
69,840
-1,200
| -2% | -$68.4K |
|
|
TYPE
33
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $3.97M | 1.36% |
124,665
-250
| -0.2% | -$7.97K |
|
|
BAY
34
DELISTED
BAYER AG SPONS ADR
BAY
| $3.91M | 1.34% |
27,553
-296
| -1% | -$42K |
|
|
MON
35
DELISTED
Monsanto Co
MON
| $3.9M | 1.34% |
33,485
+12,850
| +62% | +$1.5M |
|
36
HCA Healthcare
HCA
$96.6B
| $3.84M | 1.31% |
80,375
+32,075
| +66% | +$1.53M |
|
|
APL
37
DELISTED
ATLAS PIPELINE PARTNERS LP UTS
APL
| $3.81M | 1.3% |
108,624
+589
| +0.5% | +$20.6K |
|
38
Philip Morris
PM
$252B
| $3.8M | 1.3% |
43,555
+815
| +2% | +$71K |
|
39
AT&T
T
$211B
| $3.66M | 1.25% |
137,654
+1,920
| +1% | +$51K |
|
|
40
Gilead Sciences
GILD
$141B
| $3.52M | 1.21% |
46,894
+23,200
| +98% | +$1.74M |
|
41
Sanofi
SNY
$112B
| $3.44M | 1.18% |
64,075
-550
| -0.9% | -$29.5K |
|
|
ESV
42
DELISTED
Ensco Rowan plc
ESV
| $3.43M | 1.17% |
14,983
+170
| +1% | +$38.9K |
|
43
Chevron
CVX
$320B
| $3.4M | 1.17% |
27,250
-175
| -0.6% | -$21.9K |
|
|
UBA
44
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $3.34M | 1.14% |
180,749
-1,500
| -0.8% | -$27.7K |
|
45
Coca-Cola
KO
$296B
| $3.3M | 1.13% |
79,831
-525
| -0.7% | -$21.7K |
|
|
CELG
46
DELISTED
Celgene Corp
CELG
| $2.79M | 0.95% |
33,000
-9,900
| -23% | -$836K |
|
47
Lockheed Martin
LMT
$106B
| $2.67M | 0.91% |
17,943
-125
| -0.7% | -$18.6K |
|
48
Comcast
CMCSA
$126B
| $2.6M | 0.89% |
100,200
| – | – |
|
49
AbbVie
ABBV
$376B
| $2.16M | 0.74% |
40,900
-100
| -0.2% | -$5.28K |
|
50
Ralph Lauren
RL
$19.1B
| $1.94M | 0.66% |
11,000
+4,000
| +57% | +$706K |
|